Follow-up in gynecological malignancies: A state of art
Autor: | Nicholas Reed, C Macchi, T Maggino, Rainer Kimmig, Nicoletta Colombo, Vesna Kesic, David Cibula, Paolo Zola |
---|---|
Přispěvatelé: | Zola, P, Macchi, C, Cibula, D, Colombo, N, Kimmig, R, Maggino, T, Reed, N, Kesic, V |
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
medicine.medical_specialty
Genital Neoplasms Female Cost-Benefit Analysis MEDLINE Medizin Obstetrics and gynaecology Quality of life Endometrial cancer Ovarian cancer medicine Humans Cervical cancer Follow-up State of art Obstetrics and Gynecology Oncology Practice Patterns Physicians' Intensive care medicine Prospective cohort study Evidence-Based Medicine business.industry Obstetrics Retrospective cohort study Evidence-based medicine medicine.disease Quality of Life Female business Follow-Up Studies |
Popis: | ObjectiveThe main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment.Materials and MethodsWe analyzed the follow up strategies for ovarian, endometrial, and cervical cancer. All of the topics discussed below arose from the “ESGO State of Art Conference—Follow-up in gynaecological malignancies” in Turin, (September 11–13, 2014;http://torino2014.esgo.org/).ResultsPhysical but these practices should be integrated with biomarkers or imaging strategies. Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge.ConclusionsAll surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes. |
Databáze: | OpenAIRE |
Externí odkaz: |